S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Clinigen Group plc: Underlying EBITDA up 19.8% and EPS up 22% (2014/9/24)|
|Clinigen Group plc Receives FDA’s First Ever Drug Shortage Assistance Award|
|MWV’s MEMS System chosen for trials of HIV-prevention medication in Africa and India|
|RedHill Biopharma Initiates Phase III Study of RHB-102 for Gastroenteritis|
|AVEO Oncology Announces Presentation of AV-380 Preclinical Data at 2nd Cancer Cachexia Conference|
|Promising Data Presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology From an Investigator-Sponsored Trial of Peregrine Pharmaceuticals' Bavituximab in Combination With Pemetrexed and Carboplatin in Front-Line Non-Small Cell Lung Cancer|
|FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab|
|People with Chronic Obstructive Pulmonary Disease (COPD) Who Received Nutrition Treatment in the Hospital Had Better Health Outcomes|
|FDA Approves Amgen's XGEVA® (Denosumab) For The Treatment Of Hypercalcemia Of Malignancy Refractory To Bisphosphonate Therapy|
|Alnylam Presents New Pre-Clinical Data with ALN-CC5, a Subcutaneously Administered RNAi Therapeutic Targeting Complement Component C5 in Development for the Treatment of Complement-Mediated Diseases|
Click above to view more mutual fund data and stats for clin - Cleopatra International Group Inc.